Literature DB >> 27306728

Physiological response to reward and extinction predicts alcohol, marijuana, and cigarette use two years later.

Karen J Derefinko1, Tory A Eisenlohr-Moul2, Jessica R Peters3, Walter Roberts4, Erin C Walsh5, Richard Milich4, Donald R Lynam6.   

Abstract

BACKGROUND: Physiological responses to reward and extinction are believed to represent the behavioral activation system (BAS) and behavioral inhibition system (BIS) constructs of Reinforcement Sensitivity Theory and underlie externalizing behaviors, including substance use. However, little research has examined these relations directly.
METHODS: We assessed individuals' cardiac pre-ejection periods (PEP) and electrodermal responses (EDR) during reward and extinction trials through the "number elimination game" paradigm. Responses represented BAS and BIS, respectively. We then examined whether these responses provided incremental utility in the prediction of future alcohol, marijuana, and cigarette use.
RESULTS: Zero-inflated Poisson (ZIP) regression models were used to examine the predictive utility of physiological BAS and BIS responses above and beyond previous substance use. Physiological responses accounted for incremental variance over previous use. Low BAS responses during reward predicted frequency of alcohol use at year 3. Low BAS responses during reward and extinction and high BIS responses during extinction predicted frequency of marijuana use at year 3. For cigarette use, low BAS response during extinction predicted use at year 3.
CONCLUSIONS: These findings suggest that the constructs of Reinforcement Sensitivity Theory, as assessed through physiology, contribute to the longitudinal maintenance of substance use.
Copyright © 2016 The Authors. Published by Elsevier Ireland Ltd.. All rights reserved.

Entities:  

Keywords:  EDR; Physiology; Pre-ejection period; RST; Substance use

Mesh:

Year:  2016        PMID: 27306728      PMCID: PMC5399675          DOI: 10.1016/j.drugalcdep.2016.01.034

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  26 in total

Review 1.  The addicted human brain: insights from imaging studies.

Authors:  Nora D Volkow; Joanna S Fowler; Gene-Jack Wang
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

2.  Reward drive and rash impulsiveness as dimensions of impulsivity: implications for substance misuse.

Authors:  Sharon Dawe; Matthew J Gullo; Natalie J Loxton
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

3.  Negative affects deriving from the behavioral approach system.

Authors:  Charles S Carver
Journal:  Emotion       Date:  2004-03

4.  Heart rate and skin conductance in behaviorally inhibited Mauritian children.

Authors:  A Scarpa; A Raine; P H Venables; S A Mednick
Journal:  J Abnorm Psychol       Date:  1997-05

5.  Pre-ejection period reactivity and psychiatric comorbidity prospectively predict substance use initiation among middle-schoolers: a pilot study.

Authors:  Sharon L Brenner; Theodore P Beauchaine
Journal:  Psychophysiology       Date:  2011-07-05       Impact factor: 4.016

6.  Behavioral activation and inhibition systems and the severity and course of depression.

Authors:  Karen L Kasch; Jonathan Rottenberg; Bruce A Arnow; Ian H Gotlib
Journal:  J Abnorm Psychol       Date:  2002-11

Review 7.  Reward deficiency syndrome: a biogenetic model for the diagnosis and treatment of impulsive, addictive, and compulsive behaviors.

Authors:  K Blum; E R Braverman; J M Holder; J F Lubar; V J Monastra; D Miller; J O Lubar; T J Chen; D E Comings
Journal:  J Psychoactive Drugs       Date:  2000-11

Review 8.  A two-dimensional neuropsychology of defense: fear/anxiety and defensive distance.

Authors:  Neil McNaughton; Philip J Corr
Journal:  Neurosci Biobehav Rev       Date:  2004-05       Impact factor: 8.989

9.  Blockade of noradrenergic receptors in the basolateral amygdala impairs taste memory.

Authors:  M I Miranda; R T LaLumiere; T V Buen; F Bermudez-Rattoni; J L McGaugh
Journal:  Eur J Neurosci       Date:  2003-11       Impact factor: 3.386

10.  Effect of varenicline on smoking cessation through smoking reduction: a randomized clinical trial.

Authors:  Jon O Ebbert; John R Hughes; Robert J West; Stephen I Rennard; Cristina Russ; Thomas D McRae; Joan Treadow; Ching-Ray Yu; Michael P Dutro; Peter W Park
Journal:  JAMA       Date:  2015-02-17       Impact factor: 56.272

View more
  1 in total

1.  The Acquired Preparedness Model of Cannabis Use in Emerging Adulthood: Comparing Within-Person and Between-Person Effects.

Authors:  Katie J Paige; Gregory A Egerton; Nolan E Ramer; Jamie L Page; Nicole Kiss; Craig R Colder
Journal:  J Stud Alcohol Drugs       Date:  2022-05       Impact factor: 3.346

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.